about
Interactions between E-cadherin and microRNA deregulation in head and neck cancers: the potential interplayBiomarkers for use in monitoring responses of nasopharyngeal carcinoma cells to ionizing radiationIL-1β promotes malignant transformation and tumor aggressiveness in oral cancer.Differential expression of long noncoding RNA in primary and recurrent nasopharyngeal carcinoma.Long non-coding RNA deregulation in tongue squamous cell carcinoma.Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines.miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma.A long non-coding RNA signature in glioblastoma multiforme predicts survival.Diagnostic Value of Methylated Human Telomerase Reverse Transcriptase in Human Cancers: A Meta-AnalysisEliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccinationDecreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinomaCordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells.Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinomaThe Efficacy of Triamcinolone Acetonide in Keloid Treatment: A Systematic Review and Meta-analysisBEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma.Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumorsCo-expression of Cytoskeletal Protein Adducin 3 and CD133 in Neurospheres and a Temozolomide-resistant Subclone of Glioblastoma.Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide.MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells.Curcumin alters the migratory phenotype of nasopharyngeal carcinoma cells through up-regulation of E-cadherin.The role of Epstein-Barr virus-encoded microRNA BART7 status of resection margins in the prediction of local recurrence after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma.MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma.Extracranial/intracranial vascular bypass and craniofacial resection: New hope for patients with locally advanced recurrent nasopharyngeal carcinoma.Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma.Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement.Indocyanine green fluorescence mapping of sentinel lymph node in patients with recurrent nasopharyngeal carcinoma after previous radiotherapy.MicroRNA-138-5p controls sensitivity of nasopharyngeal carcinoma to radiation by targeting EIF4EBP1.Functional significance of the long non-coding RNA RP11-169D4.1 as a metastasis suppressor in laryngeal squamous cell carcinoma by regulating CDH1.Surgical salvage for recurrent retropharyngeal lymph node metastasis in nasopharyngeal carcinoma.Transoral robotic total laryngopharyngectomy and free jejunal flap reconstruction for hypopharyngeal cancer.Epstein-Barr virus-encoded microRNA BART7 downregulates major histocompatibility complex class I chain-related peptide A and reduces the cytotoxicity of natural killer cells to nasopharyngeal carcinomaWhole-organ histopathological study of recurrent nasopharyngeal carcinoma
P50
Q26866533-AA522094-42B2-4506-B4CE-6DCB06526704Q27010624-ACB33DC1-FDDA-4356-B264-7679B6636639Q30981861-D12AAD41-FEA3-4ED0-8E0B-AD2630D453DEQ33562419-F5B52C64-3D09-4A52-8613-A24D7A46B10AQ33876539-665AE683-BA12-42DB-8783-2E0F7CCA361AQ34042498-1725517E-96F7-414E-B86E-9C230C148AD4Q34092121-C055DF3A-6F82-48FA-9B19-35947950A9B6Q34347963-C7FEABE6-1347-40A3-B574-CE831EA9F038Q36400631-6121319A-0635-410A-94B7-A00317503E93Q36489891-7A608474-B70D-414B-97DC-7805DA5B2FF2Q37001160-38B4D7D0-3A80-4ECC-8697-D470502448E2Q37057370-E02F92FC-E56B-4B33-9DAC-426F0E170F69Q37437275-A943303C-03FE-455C-BD5C-4EDE662BDAD8Q37532880-FBCF0A6C-66CD-49F1-A356-D3A9FE358777Q37648125-E557E6E7-C3A7-4D19-9005-39CD821790ADQ37746309-A721C1A5-723E-4951-BA17-6927248C2F40Q38246793-B44F935B-06FB-4132-A9CA-F18039D04106Q38814262-5EF5D3C1-2A66-45F7-A349-450971192B36Q38988448-D1CAA7D1-614F-48CE-A7DE-F76EC7E9D203Q39010278-6211C8D0-88C4-45F6-BDF5-EC8898E2CA59Q39319634-5C828EB6-8D28-43AA-BE5E-D836800078D2Q39321003-D7D793A9-983A-42A1-8834-C398EBB106DFQ39671761-0D62E326-7337-4142-A676-A3B4E3CEE784Q41752446-20833B3C-B442-42A3-B762-264064709D41Q42323431-02616083-5152-4F1B-99FA-6DB64DF7E0ADQ45351163-5A9E7B0D-2A49-43CF-A4A3-5F08D701020AQ47644279-5C64FA2E-579C-4A07-9390-55F50B499EB7Q47909190-8A269D9E-26E0-4CBC-8B97-D07B42E7226BQ48103860-3A94CF32-278E-48EE-B82E-DC7F93281893Q50437913-608D0989-5E83-40AB-B7EC-859863B99FA8Q50958649-09B127D6-31D3-4DCA-8E2C-FBA5DC6B21BFQ50986257-B1214566-D23D-4555-8ABE-FE9203B4CBBDQ53117482-F57218A2-5787-47B1-BFF2-A09C1BD195C6Q53799349-32A8F6D8-A1DB-4D3E-B15C-0FDC102908C1Q59354218-7CB06901-0CFE-4E33-98D2-3BC0336A9BBEQ86861460-2C7E946A-BBAA-4420-A677-4C0666C26865
P50
description
investigador
@es
researcher
@en
name
Stanley Thian Sze Wong
@en
type
label
Stanley Thian Sze Wong
@en
prefLabel
Stanley Thian Sze Wong
@en
P31
P496
0000-0002-8245-4019